Pain relief vials back on market

Pet drugs firm Animalcare has resumed sales of its Buprecare pain relief vials after an 18-month break in supply.

The York-based group revealed in July 2011 its contract manufacturer Recipharm was closing its sterile injectable production factory with immediate effect, disrupting Animalcare’s supply of Buprecare single dose ampoules to the UK and Europe.

Yesterday, the firm said it has signed a new deal with a German contract manufacturer which has a “substantial” sterile injectables facility in France. That factory has been approved to manufacture Buprecare single dose ampoules and Animalcare said the product is now available for supply once again.

Hide Ad
Hide Ad

Animalcare chief executive Stephen Wildridge said: “It was very disappointing to lose our marketing leading product Buprecare ampoules so abruptly.

“However, after some excellent work from the Animalcare team in identifying and working with a very competent manufacturer we are now back in a market that has been eagerly awaiting our return and with a supplier that puts us in an even stronger position.

“It’s a very good way to start 2013.”

The company said it is “confident” about the new supply of Buprecare ampoules and of returning to sales levels previously seen. “The company is now focusing on bringing the product back to market,” it said.

It added the Buprecare multidose vial, an analgesic for cats and dogs launched in March 2012, continues to sell well.

Related topics: